rs150754122
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_033028.5(BBS4):c.712-17C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0144 in 1,613,960 control chromosomes in the GnomAD database, including 201 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.010 ( 14 hom., cov: 29)
Exomes 𝑓: 0.015 ( 187 hom. )
Consequence
BBS4
NM_033028.5 intron
NM_033028.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.50
Publications
0 publications found
Genes affected
BBS4 (HGNC:969): (Bardet-Biedl syndrome 4) This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse. The similar phenotypes exhibited by mutations in BBS gene family members are likely due to the protein's shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene has sequence similarity to O-linked N-acetylglucosamine (O-GlcNAc) transferases in plants and archaebacteria and in human forms a multi-protein "BBSome" complex with seven other BBS proteins. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
BBS4 Gene-Disease associations (from GenCC):
- Bardet-Biedl syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 15-72731288-C-G is Benign according to our data. Variant chr15-72731288-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0103 (1562/152130) while in subpopulation NFE AF = 0.0168 (1143/67974). AF 95% confidence interval is 0.016. There are 14 homozygotes in GnomAd4. There are 678 alleles in the male GnomAd4 subpopulation. Median coverage is 29. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BBS4 | NM_033028.5 | c.712-17C>G | intron_variant | Intron 10 of 15 | ENST00000268057.9 | NP_149017.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0103 AC: 1561AN: 152012Hom.: 14 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
1561
AN:
152012
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00963 AC: 2422AN: 251454 AF XY: 0.00937 show subpopulations
GnomAD2 exomes
AF:
AC:
2422
AN:
251454
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0148 AC: 21610AN: 1461830Hom.: 187 Cov.: 31 AF XY: 0.0145 AC XY: 10512AN XY: 727234 show subpopulations
GnomAD4 exome
AF:
AC:
21610
AN:
1461830
Hom.:
Cov.:
31
AF XY:
AC XY:
10512
AN XY:
727234
show subpopulations
African (AFR)
AF:
AC:
75
AN:
33478
American (AMR)
AF:
AC:
294
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
364
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
308
AN:
86246
European-Finnish (FIN)
AF:
AC:
230
AN:
53412
Middle Eastern (MID)
AF:
AC:
30
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
19457
AN:
1111976
Other (OTH)
AF:
AC:
852
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1201
2401
3602
4802
6003
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
720
1440
2160
2880
3600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0103 AC: 1562AN: 152130Hom.: 14 Cov.: 29 AF XY: 0.00912 AC XY: 678AN XY: 74368 show subpopulations
GnomAD4 genome
AF:
AC:
1562
AN:
152130
Hom.:
Cov.:
29
AF XY:
AC XY:
678
AN XY:
74368
show subpopulations
African (AFR)
AF:
AC:
113
AN:
41516
American (AMR)
AF:
AC:
143
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
42
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5172
South Asian (SAS)
AF:
AC:
14
AN:
4812
European-Finnish (FIN)
AF:
AC:
50
AN:
10576
Middle Eastern (MID)
AF:
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
AC:
1143
AN:
67974
Other (OTH)
AF:
AC:
31
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
74
148
221
295
369
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Bardet-Biedl syndrome 4 Benign:1
Oct 20, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Bardet-Biedl syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.